AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Key performance metrics for wide market index funds in retirement include return consistency, volatility, and cost efficiency to monitor progress.
28,290 articlesAbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Christina Qi, once at the helm of a high-speed trading firm, has launched Databento into the market data arena. The s...
Stocks in the semiconductor sector led gains, with intel rallied today as investors weighed AI demand, supply chain p...
Dycom Industries sits at the center of the U.S. buildout wave. This article breaks down the 2026 earnings outlook, ke...
Kohl's stock moved in dramatic strides after its latest earnings report, tumbling early before a sharp rally. This ar...
Base58 Labs unveils BASIS 2026 blueprint, aiming to redefine institutional access to BTC, ETH, SOL, and PAXG through ...
A DRAM-focused memory ETF delivered triple-digit gains in 2026, outperforming many AI names as investors weighed AI i...
As silver prices drive market chatter in 2026, traders compare SIL and SILJ. The choice hinges on exposure to establi...
Archer Aviation takes a bold leap with Halo, a pilotless, hybrid-electric tilt-rotor aircraft developed with Anduril....
In 2026, some markets will heat up while others cool down. This guide outlines the 10 markets where prices will rise ...
On a day when the market generally slipped, Plug Power captured attention with a solid quarterly report. This piece b...
In a challenging crypto bear market, XRP and Dogecoin face different hurdles and opportunities. This guide breaks dow...